The Israeli panel recommends a fourth COVID-19 vaccination for all adults


The Israeli Expert Committee on Tuesday said that if an individual receives a third dose or recovers from illness at least 5 months before the fourth dose, a fourth dose to all persons over the age of 18. I recommended COVID-19 vaccination.

January 25 statementThe Israeli Ministry of Health (MOH) has more than tripled its defense against severe COVID-19 with a fourth injection and doubled its defense against infection compared to those who received three doses. He said that a recommendation was made given preliminary data to show that.

MOH is listed on the attached sheet statement This data was found to be from a preliminary analysis conducted by a team of researchers at the MOH, Weizmann Institute of Science, Technion, Hebrew University, and the Gartner Institute at the Sheva Medical Center.

Israel, one of the first countries to deploy shots about a year ago, already offers a second booster for people over the age of 60 or those at high risk of contract. CCP (Chinese Communist Party) virus, People with immunodeficiency and medical staff.

Implementation of the latest measures must still be approved by the Secretary of Health, the Ministry of Health said. It wasn’t immediately clear when that would happen.

The total number of active cases in the country has increased to about 550,000, of which 856 are currently hospitalized, MOH figures indicate that they are seriously ill.

With Israel reporting more than 83,500 positive cases on Monday, there is an advisory board recommending a fourth dose for all adults. This is the largest increase in infectious diseases since the start of the pandemic almost two years ago.

Health officials said the fourth shot wanted to slow the wave of infection caused by the Omicron variant of the CCP virus, but some Israeli researchers said Pfizer’s COVID-19 vaccine. The second booster shot is high enough to protect the recipient from infection from Omicron. Many of Israel’s COVID-19 vaccination programs use Pfizer Jab.

Epoch Times Photo
A vial of Pfizer-BioNTech COVID-19 vaccine is shown in the file photo. (Justin Sullivan / Getty Images)

“Two weeks after the fourth vaccination, there was a significant increase in antibodies compared to after the third vaccination, but not enough for Omicron,” said Professor Gili Regev-Yochay, Principal Investigator at the Sheva Medical Center. Says. I told reporters At an online briefing.

According to January 20 data, Israel has already taken about half of its citizens at the third dose, but the case rate has skyrocketed since the advent of Omicron, leading the world in new daily cases per capita. is doing.

Eran Segal, a biologist at the Weizmann Institute of Science, examined the data, compared the number of seven-day moving averages for each country, and then explained that Israel was the top Times of Israel. report..

Omicron has proven superior to previous strains in avoiding antibodies induced by the COVID-19 vaccine, infecting millions of vaccinated people worldwide. It is triggering new efforts by many countries to boost people.

from NTD News

Lorenz Duchamps

follow